
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter D - Drugs for Human Use
#### PART 312 - INVESTIGATIONAL NEW DRUG APPLICATION
##### Subpart B - Investigational New Drug Application (IND)
###### ยง 312.23 IND content and format.
####### a,b,c,d,e,f

(iv) A brief description of the overall plan for investigating the drug product for the following year. The plan should include the following: () The rationale for the drug or the research study; () the indication(s) to be studied; () the general approach to be followed in evaluating the drug; () the kinds of clinical trials to be conducted in the first year following the submission (if plans are not developed for the entire year, the sponsor should so indicate); () the estimated number of patients to be given the drug in those studies; and () any risks of particular severity or seriousness anticipated on the basis of the toxicological data in animals or prior studies in humans with the drug or related drugs.

(4) [Reserved]
